Krilogy Financial’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Krilogy Financial’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-700	Closed	-$12K	–	814
2018 Q3	$12K	Buy	+700	New	+$12K	﹤0.01%	511

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Krilogy Financial's ECYT Position: Q4 2018 in Review

Krilogy Financial sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 700 shares — an estimated $12K sold.

Krilogy Financial first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $12K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Krilogy Financial reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Krilogy Financial sold 700 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $12K.
Krilogy Financial first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
Krilogy Financial's Endocyte, Inc. Common Stock position peaked at $12K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.